Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer

Affiliated Hospital of Hebei University, Baoding

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

Xiangya Hospital Central South University, Changsha

Heping Hospital Affiliated to Changzhi Medical College, Changzhi

Sichuan Cancer Hospital & Institute, Chengdu

Sichuan Provincial People's Hospital, Chengdu

The Affiliated Hospital of Guizhou Medical University, Guiyang

Hainan Cancer Hospital, Haikou

Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei

Lanzhou University Second Hospital, Lanzhou

Changhai Hospital, Shanghai

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

Liaoning Cancer Hospita & Institute, Shenyang

The Fourth Hospital of Hebei Medical University, Shijiazhuang

Jilin Guowen Hospital, Siping

Shanxi Provincial Cancer Hospital, Taiyuan

First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

Tangdu Hospital, Xi'an

Yantai Yuhuangding Hospital, Yantai

Henan Provincial Cancer Hospital, Zhengzhou

Affiliated Hospital of Jiangsu University, Zhenjiang